GENE ONLINE|News &
Discovery
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
AstraZeneca’s Imfinzi Wins U.S. Approval for Perioperative Gastric Cancer Treatment with FLOT
2025-11-26
Indian Generics Gain Ground in China as the Global Procurement Landscape Demands a New Industrial Model
2025-11-13
FDA Approves Roche’s Gazyva for Lupus Nephritis, Bringing New Hope to 1.7 Million Patients Worldwide
2025-10-21
The Biologics Landscape Is Changing—Fast: CDMOs Race to Integrate Development, Scale, and Next-Gen Modalities
2025-10-20
Strategic Outsourcing: How CDMO Partnerships Are Tipping the Scales from Cost Efficiency to Supply Chain Resilience
2025-10-20
Bora Pharmaceuticals Enters U.S. Capital Market with Level 1 ADR, Accelerates CDMO & LFC Growth
2025-10-14
EGFR Lung Cancer 2025: AstraZeneca’s Tagrisso vs J&J’s Rybrevant in Global Trials Highlight Efficacy and Tolerability Trade-Offs
2025-09-30
Breakthrough in Breast Cancer for 2.3 Million Women: evERA Trial Delivers 70% ER Positive Insight with Giredestrant Combo
2025-09-25
Pilatus Biosciences Advances CD36 Metabolic Checkpoint to Revolutionize Tumor Microenvironment Cancer Therapy
2025-09-03
At-Home Alzheimer’s Therapy: FDA Clears Leqembi IQLIK Autoinjector for Maintenance Dosing
2025-09-03
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
